Gut microbiota transfer from autoimmune dry eye mice imprints stereotypic B cell receptor repertoires in the lacrimal gland and induces disease - Top-Institutions - MDSpire

Gut microbiota transfer from autoimmune dry eye mice imprints stereotypic B cell receptor repertoires in the lacrimal gland and induces disease

  • By

  • Seonghwan Kim

  • Soobin Lee

  • Soyeon Ju

  • Jaewoong Bae

  • Jin Suk Ryu

  • Yerim Heo

  • Wan Jae Choi

  • Kum-Joo Shin

  • Seok-Jin Kim

  • Namphil Kim

  • Hansol Choi

  • Jiyun Park

  • Eunjae Lee

  • Chang Ho Yoon

  • Sunghoon Kwon

  • Junho Chung

  • Mee Kum Kim

  • June 16, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The Jackson Laboratory
    The Jackson Laboratory

    Bar Harbor, Maine

    Key Differentiators

    • Ophthalmology

  • #2

    National Eye Institute
    National Eye Institute

    Bethesda, Maryland

    Key Differentiators

    • Ophthalmology

  • #3

    Applied Biosystems
    Applied Biosystems

    Foster City, California

    Key Differentiators

    • Ophthalmology

  • #4

    Qiagen
    Qiagen

    Hilden, Germany

    Key Differentiators

    • Ophthalmology

  • #5

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology

Original Source(s)

Gut microbiota transfer from autoimmune dry eye mice imprints stereotypic B cell receptor repertoires in the lacrimal gland and induces disease

  • by Seonghwan Kim, Soobin Lee, Soyeon Ju, Jaewoong Bae, Jin Suk Ryu, Yerim Heo, Wan Jae Choi, Kum-Joo Shin, Seok-Jin Kim, Namphil Kim, Hansol Choi, Jiyun Park, Eunjae Lee, Chang Ho Yoon, Sunghoon Kwon, Junho Chung, Mee Kum Kim

  • June 16, 2026

Related Content

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.